HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor.

Abstract
Although ameloblastoma and adenomatoid odontogenic tumor (AOT) belong to the same group according to the World Health Organization, they show different biologic behaviors. PCNA, an amplifier of cell proliferation, and p53, a tumor suppressor protein, are overexpressed in some odontogenic lesions. The purpose of this study was to immunohistochemically evaluate the expression of p53 and PCNA to clarify the possible role of these proteins in different behaviors of ameloblastoma and AOT. The immunohistochemical expression of PCNA and p53 was determined in 30 solid ameloblastomas and 12 AOTs. Statistical tests including one-way ANOVA, t-test, chi-square, Mann-Whitney U and Kendall were used to analyze the data. All tissue sections (except one specimen of plexiform ameloblastoma) exhibited immunoexpression for p53. PCNA was expressed in all specimens. There was no significant difference in PCNA expression between ameloblastomas and AOTs (P > 0.05). For p53, there was no statistical difference between subtypes of ameloblastomas (P > 0.05), whereas statistical differences were observed between ameloblastomas and AOTs (P < 0.001). There was no statistical difference in PCNA intensity of staining between ameloblastomas and AOTs (P > 0.05), whereas the p53 intensity in ameloblastomas was stronger than AOTs (P < 0.05). Positive correlation between PCNA and p53 was observed. We concluded that PCNA overexpression is not responsible for the difference in clinical behavior of these two lesions, whereas the expression of p53 in ameloblastoma may explain the more aggressive nature of this tumor compared with AOT.
AuthorsJahanshah Salehinejad, Reza Zare-Mahmoodabadi, Shadi Saghafi, Amir-Hossien Jafarian, Narges Ghazi, Ali-Reza Rajaei, Parviz Marouzi
JournalJournal of oral science (J Oral Sci) Vol. 53 Issue 2 Pg. 213-7 (Jun 2011) ISSN: 1880-4926 [Electronic] Japan
PMID21712626 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Proliferating Cell Nuclear Antigen
  • TP53 protein, human
  • Tumor Suppressor Protein p53
Topics
  • Adenocarcinoma (genetics, pathology)
  • Adult
  • Ameloblastoma (classification, genetics, pathology)
  • Female
  • Gene Expression Regulation, Neoplastic (genetics)
  • Humans
  • Immunohistochemistry
  • Lymphoma (genetics, pathology)
  • Male
  • Odontogenic Tumors (genetics, pathology)
  • Proliferating Cell Nuclear Antigen (analysis, genetics)
  • Tumor Suppressor Protein p53 (analysis, genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: